Rathbones Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7M Buy
369,792
+12,044
+3% +$792K 0.09% 123
2026
Q1
$25.5M Sell
357,748
-7,597
-2% -$599K 0.1% 115
2025
Q4
$30M Sell
365,345
-4,754
-1% -$370K 0.12% 112
2025
Q3
$27.8M Buy
370,099
+63,669
+21% +$4.75M 0.11% 116
2025
Q2
$22.7M Buy
306,430
+17,234
+6% +$1.2M 0.1% 125
2025
Q1
$23.3M Buy
289,196
+10,859
+4% +$933K 0.11% 120
2024
Q4
$21.8M Buy
278,337
+54,748
+24% +$4.65M 0.11% 122
2024
Q3
$21M Buy
223,589
+100,899
+82% +$8.47M 0.11% 119
2024
Q2
$9.56M Buy
122,690
+22,655
+23% +$1.85M 0.05% 148
2024
Q1
$9.09M Buy
100,035
+49,341
+97% +$4.11M 0.05% 146
2023
Q4
$3.92M Buy
50,694
+413
+0.8% +$28.9K 0.03% 198
2023
Q3
$3.42M Buy
50,281
+7,069
+16% +$514K 0.02% 209
2023
Q2
$3.51M Sell
43,212
-409
-0.9% -$32.6K 0.03% 166
2023
Q1
$3.58M Sell
43,621
-522
-1% -$37.3K 0.04% 169
2022
Q4
$3.03M Buy
+44,143
New +$2.54M 0.03% 173

Other funds holding GEHC

Rathbones Group's GEHC Position: Q2 2026 in Review

Rathbones Group increased its GE HealthCare (GEHC) stake by 3.4% in Q2 2026, buying an estimated $792K and bringing the position to 369,792 shares worth $23.7M. The position accounts for 0.09% of the portfolio, ranked #123.

Rathbones Group first reported a position in GEHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $30M in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Rathbones Group held 369,792 shares of GE HealthCare worth $23.7M as of Q2 2026.
  • Rathbones Group bought 12,044 GE HealthCare shares in Q2 2026, an estimated $792K.
  • GE HealthCare made up 0.09% of Rathbones Group's portfolio in Q2 2026, its #123 holding.
  • Rathbones Group first reported a position in GE HealthCare in Q4 2022 and has held it in 15 quarters since.
  • Rathbones Group's GE HealthCare position peaked at $30M in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.